1. Home
  2. VYX vs NVAX Comparison

VYX vs NVAX Comparison

Compare VYX & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.96

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$10.85

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
NVAX
Founded
1881
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
VYX
NVAX
Price
$6.96
$10.85
Analyst Decision
Strong Buy
Hold
Analyst Count
7
9
Target Price
$14.64
$11.33
AVG Volume (30 Days)
2.2M
4.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.02
Revenue Growth
N/A
64.69
52 Week Low
$6.46
$5.01
52 Week High
$14.67
$11.85

Technical Indicators

Market Signals
Indicator
VYX
NVAX
Relative Strength Index (RSI) 33.87 61.55
Support Level N/A $6.43
Resistance Level $11.17 $11.85
Average True Range (ATR) 0.44 0.76
MACD -0.07 -0.00
Stochastic Oscillator 19.05 62.92

Price Performance

Historical Comparison
VYX
NVAX

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: